Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A

Experimental Neurology

Volumn 218, Issue 2, 2009, Pages 268-273

  Cartoni, Romain ^a   Martinou, Jean Claude ^a  

^a Department of cell biology ^*  (Switzerland)

Author keywords

Charcot Marie Tooth disease; Mfn2; Mitochondrial fusion; Neuropathy

Indexed keywords

MITOFUSIN 2; MUTANT PROTEIN;

GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPOTHESIS; MITOCHONDRION; NERVE CELL; NEURITE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUTATION; NEURONS;

EID: 67649803117     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.05.003     Document Type: Review

References (55)

1. Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., Bhattacharya S.S., and Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26 (2000) 211-215
2. Bach D., Pich S., Soriano F.X., Vega N., Baumgartner B., Oriola J., Daugaard J.R., Lloberas J., Camps M., Zierath J.R., Rabasa-Lhoret R., Wallberg-Henriksson H., Laville M., Palacin M., Vidal H., Rivera F., Brand M., and Zorzano A. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278 (2003) 17190-17197
3. Baloh R.H., Schmidt R.E., Pestronk A., and Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J. Neurosci. 27 (2007) 422-430
4. Barisic N., Claeys K.G., Sirotkovic-Skerlev M., Lofgren A., Nelis E., De Jonghe P., and Timmerman V. Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Ann. Hum. Genet. 72 (2008) 416-441
5. Cartoni R., Leger B., Hock M.B., Praz M., Crettenand A., Pich S., Ziltener J.L., Luthi F., Deriaz O., Zorzano A., Gobelet C., Kralli A., and Russell A.P. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 567 (2005) 349-358
6. Chan D.C. Dissecting mitochondrial fusion. Dev. Cell. 11 (2006) 592-594
7. Charcot J., and Marie P. Sur une forme particulière d'atrophie musculaire progressive, souvent familiale débutant par les pieds et les jambes et atteignant plus tard les mains. Rev. Med. 6 (1886) 138
8. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., and Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell. Biol. 160 (2003) 189-200
9. Chen H., McCaffery J.M., and Chan D.C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130 (2007) 548-562
10. Chen K.H., Guo X., Ma D., Guo Y., Li Q., Yang D., Li P., Qiu X., Wen S., Xiao R.P., and Tang J. Dysregulation of HSG triggers vascular proliferative disorders. Nat. Cell. Biol. 6 (2004) 872-883
11. Cho H.J., Sung D.H., Kim B.J., and Ki C.S. Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot-Marie-Tooth neuropathy type 2. Clin. Genet. 71 (2007) 267-272
12. Chung K.W., Kim S.B., Park K.D., Choi K.G., Lee J.H., Eun H.W., Suh J.S., Hwang J.H., Kim W.K., Seo B.C., Kim S.H., Son H., Kim S.M., Sunwoo N., and Choi B.O. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129 (2006) 2103-2118
13. Davies V.J., Hollins A.J., Piechota M.J., Yip W., Davies J.R., White K.E., Nicols P.P., Boulton M.E., and Votruba M. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum. Mol. Genet. 16 (2007) 1307-1318
14. de Brito O.M., and Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456 (2008) 605-610
15. Delettre C., Lenaers G., Griffoin J.M., Gigarel N., Lorenzo C., Belenguer P., Pelloquin L., Grosgeorge J., Turc-Carel C., Perret E., Astarie-Dequeker C., Lasquellec L., Arnaud B., Ducommun B., Kaplan J., and Hamel C.P. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26 (2000) 207-210
16. Detmer S.A., and Chan D.C. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J. Cell. Biol. 176 (2007) 405-414
17. Detmer S.A., and Chan D.C. Functions and dysfunctions of mitochondrial dynamics. Nat. Rev. Mol. Cell. Biol. 8 (2007) 870-879
18. Detmer S.A., Vande Velde C., Cleveland D.W., and Chan D.C. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. Hum. Mol. Genet. 17 (2008) 367-375
19. Eura Y., Ishihara N., Yokota S., and Mihara K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J. Biochem. (Tokyo). 134 (2003) 333-344
20. Glater E.E., Megeath L.J., Stowers R.S., and Schwarz T.L. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J. Cell. Biol. 173 (2006) 545-557
21. Guo X., Macleod G.T., Wellington A., Hu F., Panchumarthi S., Schoenfield M., Marin L., Charlton M.P., Atwood H.L., and Zinsmaier K.E. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47 (2005) 379-393
22. Hales K.G., and Fuller M.T. Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell 90 (1997) 121-129
23. Hermann G.J., Thatcher J.W., Mills J.P., Hales K.G., Fuller M.T., Nunnari J., and Shaw J.M. Mitochondrial fusion in yeast requires the transmembrane GTPase Fzo1p. J. Cell. Biol. 143 (1998) 359-373
24. Hollenbeck P.J., and Saxton W.M. The axonal transport of mitochondria. J. Cell. Sci. 118 (2005) 5411-5419
25. Houlden H., and Reilly M.M. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med. 8 (2006) 43-62
26. Ishihara N., Eura Y., and Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J. Cell. Sci. 117 (2004) 6535-6546
27. Johnston P.B., Gaster R.N., Smith C., and Tripathi R.C. A clinicopathologic study of autosomal dominant optic atrophy. Am. J. Ophthalmol. 88 (1979) 868-875
28. Jones B.A., and Fangman W.L. Mitochondrial DNA maintenance in yeast requires a protein containing a region related to the GTP-binding domain of dynamin. Genes Dev. 6 (1992) 380-389
29. Kijima K., Numakura C., Izumino H., Umetsu K., Nezu A., Shiiki T., Ogawa M., Ishizaki Y., Kitamura T., Shozawa Y., and Hayasaka K. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum. Genet. 116 (2005) 23-27
30. Kim J.Y., Hwang J.M., Ko H.S., Seong M.W., Park B.J., and Park S.S. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology 64 (2005) 966-972
31. Kjer P., Jensen O.A., and Klinken L. Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta. Ophthalmol. (Copenh). 61 (1983) 300-312
32. Koshiba T., Detmer S.A., Kaiser J.T., Chen H., McCaffery J.M., and Chan D.C. Structural basis of mitochondrial tethering by mitofusin complexes. Science 305 (2004) 858-862
33. Legros F., Malka F., Frachon P., Lombes A., and Rojo M. Organization and dynamics of human mitochondrial DNA. J. Cell. Sci. 117 (2004) 2653-2662
34. Liesa M., Borda-d'Agua B., Medina-Gomez G., Lelliott C.J., Paz J.C., Rojo M., Palacin M., Vidal-Puig A., and Zorzano A. Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS ONE 3 (2008) e3613
35. Loiseau D., Chevrollier A., Verny C., Guillet V., Gueguen N., Pou de Crescenzo M.A., Ferre M., Malinge M.C., Guichet A., Nicolas G., Amati-Bonneau P., Malthiery Y., Bonneau D., and Reynier P. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann. Neurol. 61 (2007) 315-323
36. Meyer zu Horste G., Prukop T., Nave K.A., and Sereda M.W. Myelin disorders: causes and perspectives of Charcot-Marie-Tooth neuropathy. J. Mol. Neurosci. 28 (2006) 77-88
37. Nangaku M., Sato-Yoshitake R., Okada Y., Noda Y., Takemura R., Yamazaki H., and Hirokawa N. KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79 (1994) 1209-1220
38. Neusch C., Senderek J., Eggermann T., Elolff E., Bahr M., and Schneider-Gold C. Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A). Eur. J. Neurol. 14 (2007) 575-577
39. Ono T., Isobe K., Nakada K., and Hayashi J.I. Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat. Genet. 28 (2001) 272-275
40. Pich S., Bach D., Briones P., Liesa M., Camps M., Testar X., Palacin M., and Zorzano A. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14 (2005) 1405-1415
41. Santel A., Frank S., Gaume B., Herrler M., Youle R.J., Fuller M.T., Legros F., Lombes A., Frachon P., and Rojo M. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. J. Cell. Sci. 116 (2003) 2763-2774
42. Santel A., and Fuller M.T. Control of mitochondrial morphology by a human mitofusin. J. Cell. Sci. 114 (2001) 867-874
43. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet. 6 (1974) 98-118
44. Sommer C., and Schroder J.M. Hereditary motor and sensory neuropathy with optic atrophy. Ultrastructural and morphometric observations on nerve fibers, mitochondria, and dense-cored vesicles. Arch. Neurol. 46 (1989) 973-977
45. Stowers R.S., Megeath L.J., Gorska-Andrzejak J., Meinertzhagen A., and Schwarz T.L. Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 36 (2002) 1063-1077
46. Tooth H. 1886. The peroneal type of progressive muscular atrophy. Dissertation, London.
47. Vallat J.M., Ouvrier R.A., Pollard J.D., Magdelaine C., Zhu D., Nicholson G.A., Grew S., Ryan M.M., and Funalot B. Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations. J. Neuropathol. Exp. Neurol. 67 (2008) 1097-1102
48. Verhoeven K., Claeys K.G., Zuchner S., Schroder J.M., Weis J., Ceuterick C., Jordanova A., Nelis E., De Vriendt E., Van Hul M., Seeman P., Mazanec R., Saifi G.M., Szigeti K., Mancias P., Butler J., Kochanski A., Ryniewicz B., De Bleecker J., Van den Bergh P., Verellen C., Van Coster R., Goemans N., Auer-Grumbach M., Robberecht W., Milic Rasic V., Nevo Y., Tournev I., Guergueltcheva V., Roelens F., Vieregge P., Vinci P., Moreno M.T., Christen H.J., Shy M.E., Lupski J.R., Vance J.M., De Jonghe P., and Timmerman V. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129 (2006) 2093-2102
49. Verstreken P., Ly C.V., Venken K.J., Koh T.W., Zhou Y., and Bellen H.J. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47 (2005) 365-378
50. Young P., and Suter U. The causes of Charcot-Marie-Tooth disease. Cell Mol. Life Sci. 60 (2003) 2547-2560
51. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., and Hirokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105 (2001) 587-597
52. Zuchner S., De Jonghe P., Jordanova A., Claeys K.G., Guergueltcheva V., Cherninkova S., Hamilton S.R., Van Stavern G., Krajewski K.M., Stajich J., Tournev I., Verhoeven K., Langerhorst C.T., de Visser M., Baas F., Bird T., Timmerman V., Shy M., and Vance J.M. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann. Neurol. 59 (2006) 276-281
53. Zuchner S., Mersiyanova V., Muglia M., Bissar-Tadmouri N., Rochelle J., Dadali E.L., Zappia M., Nelis E., Patitucci A., Senderek J., Parman Y., Evgrafov O., Jonghe P.D., Takahashi Y., Tsuji S., Pericak-Vance M.A., Quattrone A., Battaloglu E., Polyakov A.V., Timmerman V., Schroder J.M., and Vance J.M. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36 (2004) 449-451
54. Zuchner S., Noureddine M., Kennerson M., Verhoeven K., Claeys K., De Jonghe P., Merory J., Oliveira S.A., Speer M.C., Stenger J.E., Walizada G., Zhu D., Pericak-Vance M.A., Nicholson G., Timmerman V., and Vance J.M. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat. Genet. 37 (2005) 289-294
55. Zuchner S., and Vance J.M. Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies. Nat. Clin. Pract. Neurol. 2 (2006) 45-53